Who owns BRIDGEBIO PHARMA INC?
- CUSIP Number: 10806xab8
Tip: Access positions for across all investors
Analyze quarterly positions in Bridgebio Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bridgebio Pharma stock
Who bought or sold BRIDGEBIO PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wolverine Asset Management | 77M | $136M | -7% | Jun 2026 |
|
| Steelhead Partners | 70M | $125B | 0% | Jun 2026 |
|
| Capstone Investment Advisors | 70M | $125M | 29% | Jun 2026 |
|
| DeepCurrents Investment Group | 50M | $90M | 429% | Jun 2026 |
|
| Moore Capital Management | 32M | $57M | 100% | Jun 2026 |
|
| Aristeia Capital | 30M | $54M | 62% | Jun 2026 |
|
| Lazard Asset Management | 26M | $466k | -26% | Jun 2026 |
|
| Graham Capital Management | 22M | $40M | 0% | Jun 2026 |
|
| 683 Capital Management | 22M | $39M | 0% | Jun 2026 |
|
| Millennium Management | 17M | $31M | -30% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 17M | $30M | 130% | Jun 2026 |
|
| Bank of America Corporation | 13M | $23M | 100% | Jun 2026 |
|
| State Street Corporation | 12M | $22M | 5% | Mar 2026 |
|
| M&G | 12M | $21M | 0% | Jun 2026 |
|
| BlackRock | 12M | $21M | 31% | Jun 2026 |
|
| FMR | 5.8M | $10M | -63% | Jun 2026 |
|
| Picton Mahoney Asset Management | 5.0M | $8.9M | 100% | Jun 2026 |
|
| State of Wisconsin Investment Board | 4.0M | $7.1M | 33% | Jun 2026 |
|
| Union Bancaire Privee, UBP SA | 3.4M | $5.1M | 89% | Jun 2026 |
|
| Amundi | 2.3M | $4.1M | 0% | Jun 2026 |
|
| Goldman Sachs Group | 1.7M | $3.0M | 320% | Jun 2026 |
|
| Ares Systematic Credit | 1.2M | $2.1M | 100% | Jun 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 1.1M | $1.9M | 47% | Jun 2026 |
|
| Agf Management | 1.0M | $1.8M | 0% | Jun 2026 |
|
| Advent Capital Management | 574k | $1.0M | 91% | Jun 2026 |
|
| Calamos Advisors | 500k | $893k | -8% | Jun 2026 |
|
| SSI Investment Management | 398k | $708k | 0% | Jun 2026 |
|
| Wells Fargo & Company | 371k | $662k | 0% | Jun 2026 |
|
| GAMCO Asset Management | 300k | $536k | 0% | Jun 2026 |
|
| Russell Investments | 113k | $203k | 64% | Jun 2026 |
|
| Virtus Fixed Income Advisers | 71k | $126k | 100% | Jun 2026 |
|
| Calamos Wealth Management | 64k | $114k | 3% | Jun 2026 |
|
| SG Americas Securities | 44k | $7.8M | -55% | Jun 2026 |
|
| Boussard & Gavaudan Investment Management | 26k | $46M | 100% | Mar 2026 |
|
| ADAR1 Capital Management | 20k | $3.5M | 0% | Jun 2026 |
|
| Virtus ETF Advisers | 18k | $32k | 100% | Jun 2026 |
|
| Traub Capital Management | 10k | $18k | 0% | Jun 2026 |
|
| Northwestern Mutual Wealth Management Company | 1.0k | $1.8k | 0% | Jun 2026 |
|
| Jones Financial Companies, L.L | 1.0k | $1.7k | 0% | Jun 2026 |
|
Who sold out of Bridgebio Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Mar 2026 | 58M | $105M |
| Tenor Capital Management | Mar 2026 | 15M | $27M |
| Camden Asset Management | Mar 2026 | 7.2M | $13B |
| Lord, Abbett & Co | Mar 2026 | 1.9M | $3.4M |
| Jane Street | Mar 2026 | 300k | $539k |
| Nomura Holdings | Mar 2026 | 28k | $2.1M |
| Pnc Financial Services | Mar 2026 | 2.0k | $360k |